Boceprevir (SCH-503034)

Catalog No. A11332

Boceprevir (SCH-503034)是一种蛋白酶抑制剂,可用于治疗C型肝炎基因型1。
  • Ueda Y, .et al. Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systems, Virus Res, 2017, May 2;235:37-48 PMID: 28322919
  • Shirasaki T, .et al. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway., Hepatology., 2014, 60(5):1519-30 PMID: 24962339
Catalog Num A11332
M. Wt 519.7
Formula C27H45N5O5
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 394730-60-0
Synonyms EBP 520, SCH 503034
SMILES CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C
Boceprevir (SCH-503034)是一种蛋白酶抑制剂,可用于治疗C型肝炎基因型1。
In vitro DMSO 90 mg/mL (173.18 mM)
Water Insoluble
Ethanol 90 mg/mL (173.18 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 19.24 mL 96.21 mL 192.42 mL
0.5 mM 3.85 mL 19.24 mL 38.48 mL
1 mM 1.92 mL 9.62 mL 19.24 mL
5 mM 0.38 mL 1.92 mL 3.85 mL

*The above data is based on the productmolecular weight 519.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.